Literature DB >> 11464921

Risk factors in the early diagnosis of ALS: North American epidemiological studies. ALS CARE Study Group.

B R Brooks1.   

Abstract

Patient-specific (endogenous) and population-specific (exogenous) risk factor analysis is identifying novel physical and chemical exposures which might be time-linked to the development of amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Electric injury in a number of case-control studies as well as prolonged exposure at work and home to agricultural chemicals in pesticides and herbicides have been identified as significant risk factors. Heavy exercise, trauma with or without bone fractures and heavy metal exposure at work have not been confirmed as risk factors. Surprisingly, occupation as a pilot or navigator has recently been identified as a potential risk factor, which will need to be confirmed. The introduction of international patient registries in North America (ALS CARE) and in Europe (ALS HPS) will facilitate future studies on the prognosis of ALS, adherence to standards of practice, quality of life and patient outcome studies. An initial survey of the ALS Patient Care Database in January 1999, when nearly 1800 patients had been entered across North America, indicated the median time from ALS onset to diagnosis is 14 months when no second opinion is requested, 12 months if the patient requests a second opinion and 10 months when the neurologist requests an additional opinion. No significant difference was found in the median time to diagnose sporadic ALS patients compared with familial ALS patients.

Entities:  

Mesh:

Year:  2000        PMID: 11464921     DOI: 10.1080/14660820052415871

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  8 in total

1.  Prospective study of chemical exposures and amyotrophic lateral sclerosis.

Authors:  M G Weisskopf; N Morozova; E J O'Reilly; M L McCullough; E E Calle; M J Thun; A Ascherio
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

2.  Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis.

Authors:  Éilis J O'Reilly; Kjetil Bjornevik; Michael A Schwarzschild; Marjorie L McCullough; Laurence N Kolonel; Loic Le Marchand; Joann E Manson; Alberto Ascherio
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-12-26       Impact factor: 4.092

Review 3.  Persistent inward currents in spinal motoneurons: important for normal function but potentially harmful after spinal cord injury and in amyotrophic lateral sclerosis.

Authors:  S M ElBasiouny; J E Schuster; C J Heckman
Journal:  Clin Neurophysiol       Date:  2010-05-11       Impact factor: 3.708

4.  Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts.

Authors:  Hao Wang; Éilis J O'Reilly; Marc G Weisskopf; Giancarlo Logroscino; Marji L McCullough; Michael J Thun; Arthur Schatzkin; Laurence N Kolonel; Alberto Ascherio
Journal:  Arch Neurol       Date:  2011-02

5.  SOD1 and cognitive dysfunction in familial amyotrophic lateral sclerosis.

Authors:  P Wicks; S Abrahams; B Papps; A Al-Chalabi; C E Shaw; P N Leigh; L H Goldstein
Journal:  J Neurol       Date:  2009-03-01       Impact factor: 4.849

6.  Altered gene expression, mitochondrial damage and oxidative stress: converging routes in motor neuron degeneration.

Authors:  Luisa Rossi; Cristiana Valle; Maria Teresa Carrì
Journal:  Int J Cell Biol       Date:  2012-05-17

7.  Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis.

Authors:  Melissa M Haulcomb; Rena M Meadows; Whitney M Miller; Kathryn P McMillan; MeKenzie J Hilsmeyer; Xuefu Wang; Wesley T Beaulieu; Stephanie L Dickinson; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

Review 8.  Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.

Authors:  Yahya E Choonara; Viness Pillay; Lisa C Du Toit; Girish Modi; Dinesh Naidoo; Valence M K Ndesendo; Sibongile R Sibambo
Journal:  Int J Mol Sci       Date:  2009-06-03       Impact factor: 6.208

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.